Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-16
DOI
10.1038/s41598-017-08422-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phospholipase Cδ1 suppresses cell migration and invasion of breast cancer cells by modulating KIF3A-mediated ERK1/2/β- catenin/MMP7 signalling
- (2017) Qing Shao et al. Oncotarget
- RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
- (2016) Pedro Barata et al. CANCER TREATMENT REVIEWS
- Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition
- (2016) Q Zhang et al. ONCOGENE
- Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer
- (2016) Fu Peng et al. TUMOR BIOLOGY
- The association between phosphatase and tensin homolog hypermethylation and patients with breast cancer, a meta-analysis and literature review
- (2016) Yi-Min Lu et al. Scientific Reports
- Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison
- (2016) Sijia Shen et al. Scientific Reports
- Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through miR-93/PTEN/Akt Signaling Pathway
- (2015) Qiaoyun Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Cytotoxic Evaluation against Breast Cancer Cells of Isoliquiritigenin Analogues from Spatholobus suberectus and Their Synthetic Derivatives
- (2015) Fu Peng et al. JOURNAL OF NATURAL PRODUCTS
- MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential
- (2015) Wei Wang et al. Journal of Zhejiang University-SCIENCE B
- MicroRNA-374a promotes esophageal cancer cell proliferation via Axin2 suppression
- (2015) YUE WANG et al. ONCOLOGY REPORTS
- A Review: The Pharmacology of Isoliquiritigenin
- (2015) Fu Peng et al. PHYTOTHERAPY RESEARCH
- LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling
- (2015) Lu Yang et al. STEM CELLS
- Dietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through WIF1 demethylation
- (2015) Neng Wang et al. Oncotarget
- The prognostic value of phosphorylated Akt in breast cancer: a systematic review
- (2015) Zu-Yao Yang et al. Scientific Reports
- Overexpression of DHX32 contributes to the growth and metastasis of colorectal cancer
- (2015) Huayue Lin et al. Scientific Reports
- MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin
- (2015) Zhiyu Wang et al. Oncotarget
- Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling
- (2014) Neng Wang et al. CARCINOGENESIS
- miR-374a promotes cell proliferation, migration and invasion by targeting SRCIN1 in gastric cancer
- (2014) Xinyun Xu et al. FEBS LETTERS
- MicroRNA-34a: a potential therapeutic target in human cancer
- (2014) X J Li et al. Cell Death & Disease
- Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer
- (2014) Y Wang et al. Cell Death & Disease
- Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells
- (2013) Kai-Lee Wang et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis
- (2013) Junchao Cai et al. JOURNAL OF CLINICAL INVESTIGATION
- Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer
- (2013) Luciano Cascione et al. PLoS One
- Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway
- (2013) Zhiyu Wang et al. PLoS One
- Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer
- (2013) Ying Li et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs
- (2012) Heidi M. Namløs et al. PLoS One
- Mammalian target of rapamycin regulates isoliquiritigenin-induced autophagic and apoptotic cell death in adenoid cystic carcinoma cells
- (2011) Gang Chen et al. APOPTOSIS
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells
- (2011) Y Huang et al. CELL DEATH AND DIFFERENTIATION
- Resveratrol alters microRNA expression profiles in A549 human non-small cell lung cancer cells
- (2011) Seunghee Bae et al. MOLECULES AND CELLS
- MicroRNAs, the DNA damage response and cancer
- (2011) Maikel D. Wouters et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Cancer microRNAs: From subtype profiling to predictors of response to therapy
- (2011) Elcie Chan et al. TRENDS IN MOLECULAR MEDICINE
- MicroRNA Control of Invasion and Metastasis Pathways
- (2011) Rahul Sreekumar et al. Frontiers in Genetics
- Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer
- (2010) Giridhar Mudduluru et al. BIOSCIENCE REPORTS
- MicroRNAs: Novel Biomarkers for Human Cancer
- (2009) C. L. Bartels et al. CLINICAL CHEMISTRY
- DIFFERENTIALLY EXPRESSED MicroRNAs IN SMALL CELL LUNG CANCER
- (2009) Edit Miko et al. EXPERIMENTAL LUNG RESEARCH
- Isoliquiritigenin, a flavonoid from licorice, plays a dual role in regulating gastrointestinal motilityin vitroandin vivo
- (2008) Gang Chen et al. PHYTOTHERAPY RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started